Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma
about
Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.Prognostic value of combined and individual expression of microRNA-1290 and its target gene nuclear factor I/X in human esophageal squamous cell carcinoma.Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.Low plasma levels of miR-101 are associated with tumor progression in gastric cancer.
P2860
Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma microRNA profiles: iden ...... hageal squamous cell carcinoma
@en
Plasma microRNA profiles: iden ...... ageal squamous cell carcinoma.
@nl
type
label
Plasma microRNA profiles: iden ...... hageal squamous cell carcinoma
@en
Plasma microRNA profiles: iden ...... ageal squamous cell carcinoma.
@nl
prefLabel
Plasma microRNA profiles: iden ...... hageal squamous cell carcinoma
@en
Plasma microRNA profiles: iden ...... ageal squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Plasma microRNA profiles: iden ...... hageal squamous cell carcinoma
@en
P2093
Atsushi Shiozaki
Daisuke Ichikawa
Eigo Otsuji
Hiroki Takeshita
Hirotaka Konishi
Hitoshi Fujiwara
Jun Kiuchi
Kazuma Okamoto
Mahito Miyamae
Shuhei Komatsu
P2860
P304
62034-62048
P356
10.18632/ONCOTARGET.11500
P407
P577
2016-08-22T00:00:00Z